Reviva Pharmaceuticals Holdings, Inc. (RVPH)
NASDAQ: RVPH · IEX Real-Time Price · USD
3.200
+0.020 (0.63%)
May 3, 2024, 4:00 PM EDT - Market closed

RVPH Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019
Net Income
-39.26-28.26-8.52-3.78-0.85
Depreciation & Amortization
00000
Share-Based Compensation
3.410.180.1500
Other Operating Activities
7.529.12-2.29-0.280.63
Operating Cash Flow
-28.32-18.96-10.67-4.07-0.22
Share Issuance / Repurchase
33.177.7931.69.720
Debt Issued / Paid
0003.110.1
Financing Cash Flow
33.177.7931.612.830.1
Net Cash Flow
4.85-11.1720.938.76-0.12
Free Cash Flow
-28.32-18.96-10.67-4.07-0.22
Free Cash Flow Per Share
-1.19-0.97-0.72-1.33-0.08
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).